Compare PRPO & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | TPCS |
|---|---|---|
| Founded | N/A | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Metal Fabrications |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 39.4M |
| IPO Year | 2000 | 2008 |
| Metric | PRPO | TPCS |
|---|---|---|
| Price | $23.34 | $3.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.4K | ★ 30.8K |
| Earning Date | 05-12-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $24,049,000.00 | ★ $34,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 29.77 | 7.72 |
| 52 Week Low | $10.60 | $2.88 |
| 52 Week High | $33.63 | $6.25 |
| Indicator | PRPO | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 55.95 |
| Support Level | $21.71 | $3.71 |
| Resistance Level | $24.30 | $4.01 |
| Average True Range (ATR) | 1.11 | 0.21 |
| MACD | 0.26 | 0.03 |
| Stochastic Oscillator | 66.88 | 73.91 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.